Actively Recruiting
Developing and Testing a Digital Health Tool for Intersectional Stigma Assessment and Reduction to Improve HIV Care in ART Centers in Nepal
Led by Possible · Updated on 2026-04-17
88
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
P
Possible
Lead Sponsor
F
Fogarty International Center of the National Institute of Health
Collaborating Sponsor
AI-Summary
What this Trial Is About
People living with HIV (PLWH) often face challenges in care due to intersectional stigma related to HIV, mental health, and other dimensions like sexual and gender minority status and ethnicity. This stigma leads to poor clinical outcomes globally. The study aims to evaluate the acceptability and feasibility of a digital health tool called INCLUDE, designed to assess and reduce intersectional stigma in ART centers in Nepal to improve HIV care engagement and outcomes. INCLUDE is a digital tool with three parts: a dynamic assessment strategy used during clinic visits to collect quantitative ratings and qualitative client perspectives on stigma; a dashboard that links stigma data with routine clinical data to identify stigma-related care barriers; and a collection of culturally appropriate, evidence-based stigma-reduction activities at individual, interpersonal, and clinic levels. The study will be conducted in four ART centers and involves both people living with HIV and healthcare workers. Participants will be involved in using the INCLUDE tool during clinic visits, providing feedback through surveys, interviews, and focus groups, and their app usage will be monitored. Researchers will measure acceptability ratings, assessment completion rates, application performance, and the implementation of stigma-reduction activities over a nine-month period. This pilot trial will gather comprehensive data to refine the tool and potentially support wider use to address intersectional stigma in HIV care.
CONDITIONS
Brief Title
Developing and Testing a Digital Health Tool for INterseCtional Stigma Assessment and Reduction at Multiple Levels and mUltiple DimEnsions (INCLUDE) to Improve HIV Care in ART Centers in Nepal
Who Can Participate
Eligibility Criteria
You may qualify if you...
- People living with HIV (PLWH) who have poor HIV outcomes, including detectable viral load after more than 6 months in care, missed clinic visits by over a month, or medication pick-up delays over 2 weeks
- Age 18 years or older
- Screening positive for mental health conditions using specified tools
- Living in the ART center's catchment area with no plans to leave during the study
- Sexual and Gender Minorities and/or Ethnic Minorities, with participant selection stratified by additional stigma dimensions
- All healthcare workers at ART centers, including counselors and ART center leads
You will not qualify if you...
- Presence of significant cognitive problems or disability that prevent participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 9 months
Participants use the INCLUDE digital health tool during clinic visits to assess and address intersectional stigma related to HIV care. This includes completing stigma assessments and accessing stigma-reduction activities tailored to their needs.
Regular clinic visits as part of routine HIV care with digital tool use during visits
Trial Site Locations
Total: 1 location
1
Possible
Kathmandu, Bagmati, Nepal
Actively Recruiting
Research Team
B
Bibhav Acharya, MD
S
Sabitri Sapkota, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here